Aidan Fry

Communicating how STADA and the off-patent medicines industry is enabling broader access to essential treatments

[Aidan Fry @AidanFrySTADA]

@alvotechpr Proud to be collaborating with @alvotechpr to bring this life-changing #biosimilar therapy to patients in Europe

[Aidan Fry @AidanFrySTADA]

Belgian health minister Frank Vandenbroucke at #PoliticoHealthcare Summit in Brussels: By constantly driving down prices of basic and essential medicines, European authorities and governments have created dangerous supply oligopolies.

[Aidan Fry @AidanFrySTADA]

Second day of the #PoliticoHealthcare summit in Brussels. Looking forward to Frank Staud presenting key insights from the #STADAHealthReport. With data from 32,000 European citizens in 16 countries, this unique research is ideally suited to inform health policy decisions.

[Aidan Fry @AidanFrySTADA]

Adrian van den Hoven of @MedicinesforEurope at #PoliticoHealthcare Summit in Brussels: European Commission communication today on medicines shortages is to be welcomed, especially planned guidelines on public procurement. https://t.co/eeRKsmI7to

[Aidan Fry @AidanFrySTADA]

MEP Christian Busoi at #PoliticoHealthcare summit in Brussels: fiscal incentives are needed to increase European production of #generic medicines. Says he is broadly supportive of the European Commission‘s proposals to modulate pharma exclusivities and incentives.

[Aidan Fry @AidanFrySTADA]

Looking forward to sharing insights from the #STADAHealthReport during the @LivePOLITICO Health Care Summit 2023 in Brussels. #PoliticoHealthCare #OneSTADA

[GB News @GBNEWS]

Busy Britons are putting themselves at risk of early death with an unhealthy habit
https://t.co/8l0kGU7FFO

[Aidan Fry @AidanFrySTADA]

Huge energy tonight in the Deutsche Bank Park supporting @Eintracht - wonder if it is a coincidence? #ElotransReload #Caringforpeopleshealth

[Aidan Fry @AidanFrySTADA]

@ParkinsonsEU Thank you @ParkinsonsEU for this outstanding collaboration on improving care for people living with Parkinson’s

[Medicines for Europe @medicinesforEU]

At our Conference Comm. @SKyriakidesEU just announced “We are open to explore a more long-term approach with a Critical Medicines Act”
This act together, with the Pharma package, will build a 🇪🇺sustainable ecosystem to prevent shortages & delivering on security of supply

[Aidan Fry @AidanFrySTADA]

@CPOstrategy @STADA @ibmconsulting @EmcsL @ProcurementLDRS @naspoVP Great lead interview with @STADA CPO Alan Rankin in the latest edition of @CPOstrategy

[Aidan Fry @AidanFrySTADA]

Tilly Metz MEP at @LivePOLITICO event on patient access to medicines: "Something needs to change. We need to rethink to prevent shortages." #ProtectingMedicines

[Aidan Fry @AidanFrySTADA]

Important discussion hosted by @LivePOLITICO and @POLITICOEurope on how best to protect patient access to off-patent medicines amid rapidly rising costs of producing and packaging essential therapies. Rigid price controls threaten to make several medicines economically unviable.

[STADA @STADA]

STADA welcomes EU approval for the treatment of a rare, progressive autoimmune disease of the kidney. The European Commission (EC) has granted conditional marketing authorization for the treatment of primary immunoglobulin (IgA) nephropathy (IgAN) in adults.
#Specialty

[Aidan Fry @AidanFrySTADA]

⁦@AESEG_genericos⁩ President Mar Fabregas, managing director of ⁦@STADA⁩ in Spain, opens day two of the ⁦@medicinesforEU⁩ annual conference. #AccessForAll #MedforEU22 #OneSTADA

[Aidan Fry @AidanFrySTADA]

It was a pleasure to moderate a session on medicine shortages today at ⁦@medicinesforEU⁩ annual conference. #AccessForAll #OneSTADA

[Medicines for Europe @medicinesforEU]

"The revision of the #EUPharmaLegislation will aim at boosting the potential of #GenericMedicines and #BiosimilarMedicines.
To ensure medicines availability for patients & reduce pharmaceutical expenditure, we need to invest more in this sector."
VP @MargSchinas at #MedsforEU22

[Aidan Fry @AidanFrySTADA]

Removing barriers to market entry for #generic and #biosimilar medicines is a key objective of the pharmaceutical legislative package that the EU Commissioner intends to bring forward by the end of this year, Commission Vice-President Margaritis Schinas told @MedicinesforEurope.

[Aidan Fry @AidanFrySTADA]

Medicines for Europe President Elisabeth Stampa opening the association's annual conference in Sitges, Spain: For every €1 invested in medicines, costs for other medical internventions such as surgery are reduced by at least €2. #ACCESSFORALL #MedsforEU22

[Aidan Fry @AidanFrySTADA]

STADA Group is delighted to be supporting Medicines for Europe in its annual conference in Sitges, Spain. Looking forward to later today moderating a panel on measures to prevent and mitigate medicines shortages. #ACCESSFORALL